EDGAR Filing Documents for 0001193125-18-315734

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-18-315734

Filing Date

2018-11-01

Accepted

2018-11-01 16:07:31

Documents

Period of Report

2018-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d599127d10q.htm	10-Q	1356011
2	EX-10.1	d599127dex101.htm	EX-10.1	15132
3	EX-31.1	d599127dex311.htm	EX-31.1	11171
4	EX-31.2	d599127dex312.htm	EX-31.2	11250
5	EX-32	d599127dex32.htm	EX-32	4823
12	GRAPHIC	g599127g1031203143717.jpg	GRAPHIC	1429
	Complete submission text file	0001193125-18-315734.txt		8958550

Data Files

Seq	Description	Document	Type	Size
6	XBRL INSTANCE DOCUMENT	teva-20180930.xml	EX-101.INS	2117574
7	XBRL TAXONOMY EXTENSION SCHEMA	teva-20180930.xsd	EX-101.SCH	90615
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20180930_cal.xml	EX-101.CAL	96313
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20180930_def.xml	EX-101.DEF	491130
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20180930_lab.xml	EX-101.LAB	617678
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20180930_pre.xml	EX-101.PRE	575509

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)